INTERIM CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Millions	Total	Total MVW Stockholders' Equity	Common Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2022			75,700,000
Beginning balance at Dec. 31, 2022	$ 2,498	$ 2,496	$ 1	$ (2,054)	$ 3,941	$ 15	$ 593	$ 2
Increase (Decrease) in Stockholders' Equity
Net income (loss)	87	87					87
Foreign currency translation adjustments	6	6				6
Derivative instrument adjustment	(3)	(3)				(3)
Share-based compensation plans (in shares)			100,000
Share-based compensation plans	(2)	(2)		2	(4)
Repurchase of common stock	(80)	(80)		(80)
Dividends	(26)	(26)					(26)
Ending balance (in shares) at Mar. 31, 2023			75,800,000
Ending balance at Mar. 31, 2023	2,480	2,478	$ 1	(2,132)	3,937	18	654	2
Beginning balance (in shares) at Dec. 31, 2022			75,700,000
Beginning balance at Dec. 31, 2022	2,498	2,496	$ 1	(2,054)	3,941	15	593	2
Increase (Decrease) in Stockholders' Equity
Net income (loss)	177
Derivative instrument adjustment	(4)
Ending balance (in shares) at Jun. 30, 2023			75,800,000
Ending balance at Jun. 30, 2023	2,478	2,476	$ 1	(2,213)	3,947	23	718	2
Beginning balance (in shares) at Mar. 31, 2023			75,800,000
Beginning balance at Mar. 31, 2023	2,480	2,478	$ 1	(2,132)	3,937	18	654	2
Increase (Decrease) in Stockholders' Equity
Net income (loss)	90	90					90	0
Foreign currency translation adjustments	6	6				6
Derivative instrument adjustment	(1)	(1)				(1)
Share-based compensation plans	11	11		1	10
Repurchase of common stock	(82)	(82)		(82)
Dividends	(26)	(26)					(26)
Ending balance (in shares) at Jun. 30, 2023			75,800,000
Ending balance at Jun. 30, 2023	$ 2,478	2,476	$ 1	(2,213)	3,947	23	718	2
Beginning balance (in shares) at Dec. 31, 2023	75,807,882		75,800,000
Beginning balance at Dec. 31, 2023	$ 2,382	2,382	$ 1	(2,332)	3,955	16	742	0
Increase (Decrease) in Stockholders' Equity
Net income (loss)	46	47					47	(1)
Foreign currency translation adjustments	1	1				1
Derivative instrument adjustment	(2)	(2)				(2)
Share-based compensation plans	1	1		5	(4)
Repurchase of common stock	(24)	(24)		(24)
Dividends	(26)	(26)					(26)
Ending balance (in shares) at Mar. 31, 2024			75,800,000
Ending balance at Mar. 31, 2024	$ 2,378	2,379	$ 1	(2,351)	3,951	15	763	(1)
Beginning balance (in shares) at Dec. 31, 2023	75,807,882		75,800,000
Beginning balance at Dec. 31, 2023	$ 2,382	2,382	$ 1	(2,332)	3,955	16	742	0
Increase (Decrease) in Stockholders' Equity
Net income (loss)	84
Derivative instrument adjustment	$ (3)
Repurchase of common stock				(36)
Ending balance (in shares) at Jun. 30, 2024	75,847,792		75,800,000
Ending balance at Jun. 30, 2024	$ 2,372	2,372	$ 1	(2,362)	3,959	1	773	0
Beginning balance (in shares) at Mar. 31, 2024			75,800,000
Beginning balance at Mar. 31, 2024	2,378	2,379	$ 1	(2,351)	3,951	15	763	(1)
Increase (Decrease) in Stockholders' Equity
Net income (loss)	38	37					37	1
Foreign currency translation adjustments	(13)	(13)				(13)
Derivative instrument adjustment	(1)	(1)				(1)
Share-based compensation plans	9	9		1	8
Repurchase of common stock	(12)	(12)		(12)
Dividends	$ (27)	(27)					(27)
Ending balance (in shares) at Jun. 30, 2024	75,847,792		75,800,000
Ending balance at Jun. 30, 2024	$ 2,372	$ 2,372	$ 1	$ (2,362)	$ 3,959	$ 1	$ 773	$ 0